About Us

The Boston University Alzheimer’s Disease Center was established in 1996 and is in its third funding cycle.  The Center is funded primarily by an Alzheimer’s Disease Core Center (ADCC) grant from the National Institute on Aging and is one of 31 federally funded Alzheimer’s Disease Centers nationwide. Our goal is to help reduce the human and economic costs associated with Alzheimer’s disease through the advancement of knowledge.

The three primary missions of our Center are to:

  1. Conduct and facilitate cutting-edge Alzheimer’s disease research
  2. Enhance clinical care for Alzheimer’s disease patients and their families
  3. Provide education regarding Alzheimer’s disease to both professional and lay audiences in the greater Boston area and beyond

BU ADC Executive Committee, clockwise from upper left: Neuropathology Core Associate Director Dr. Thor Stein, Neuropathology Core Director Dr. Ann McKee, Dr. Lee Goldstein, Center Director Dr. Neil Kowall, Clinical Core Director Dr. Robert Stern, Data Management Core Director Christine Chaisson, Education Core Director Dr. Andrew Budson, Former Center Associate Director Dr. Angela Jefferson

BU ADC Executive Committee, clockwise from upper left: Neuropathology Core Associate Director Dr. Thor Stein, Neuropathology Core Director Dr. Ann McKee, Dr. Lee Goldstein, Center Director Dr. Neil Kowall, Clinical Core Director Dr. Robert Stern, Data Management Core Director Christine Chaisson, Education Core Director Dr. Andrew Budson, Former Center Associate Director Dr. Angela Jefferson

Get Involved

Clinical Care 1
Learn about study participation and other ways to contribute to Alzheimer's research

BU ADC Bulletin

BU ADC Fall 2011 Newsletter cover pic
  • A tribute to Richard Roye, Sr., inspiring Alzheimer’s advocate
  • News about BU ADC’s recent renewal
  • A feature on the importance of research participation